Histological response is not a prognostic factor after neoadjuvant chemotherapy in advanced-stage ovarian cancer with no residual disease.

MLA

Ferron, Jean-Guillaume, et al. “Histological Response Is Not a Prognostic Factor after Neoadjuvant Chemotherapy in Advanced-Stage Ovarian Cancer with No Residual Disease.” European Journal of Obstetrics, Gynecology, and Reproductive Biology, vol. 147, no. 1, Nov. 2009, pp. 101–05. EBSCOhost, https://doi.org/10.1016/j.ejogrb.2009.07.016.

APA

Ferron, J.-G., Uzan, C., Rey, A., Gouy, S., Pautier, P., Lhommé, C., Duvillard, P., & Morice, P. (2009). Histological response is not a prognostic factor after neoadjuvant chemotherapy in advanced-stage ovarian cancer with no residual disease. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 147(1), 101–105. https://doi.org/10.1016/j.ejogrb.2009.07.016

Chicago

Ferron, Jean-Guillaume, Catherine Uzan, Annie Rey, Sebastien Gouy, Patricia Pautier, Catherine Lhommé, Pierre Duvillard, and Philippe Morice. 2009. “Histological Response Is Not a Prognostic Factor after Neoadjuvant Chemotherapy in Advanced-Stage Ovarian Cancer with No Residual Disease.” European Journal of Obstetrics, Gynecology, and Reproductive Biology 147 (1): 101–5. doi:10.1016/j.ejogrb.2009.07.016.